Accelerated Clearance and Degradation of Cell-Free HIV by Neutralizing Antibodies Occurs via FcγRIIb on Liver Sinusoidal Endothelial Cells by Endocytosis
Open Access
- 15 March 2021
- journal article
- research article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 206 (6), 1284-1296
- https://doi.org/10.4049/jimmunol.2000772
Abstract
Neutralizing Abs suppress HIV infection by accelerating viral clearance from blood circulation in addition to neutralization. The elimination mechanism is largely unknown. We determined that human liver sinusoidal endothelial cells (LSEC) express FcγRIIb as the lone Fcγ receptor, and using humanized FcγRIIb mouse, we found that Ab-opsonized HIV pseudoviruses were cleared considerably faster from circulation than HIV by LSEC FcγRIIb. Compared with humanized FcγRIIb-expressing mice, HIV clearance was significantly slower in FcγRIIb knockout mice. Interestingly, a pentamix of neutralizing Abs cleared HIV faster compared with hyperimmune anti-HIV Ig (HIVIG), although the HIV Ab/Ag ratio was higher in immune complexes made of HIVIG and HIV than pentamix and HIV. The effector mechanism of LSEC FcγRIIb was identified to be endocytosis. Once endocytosed, both Ab-opsonized HIV pseudoviruses and HIV localized to lysosomes. This suggests that clearance of HIV, endocytosis, and lysosomal trafficking within LSEC occur sequentially and that the clearance rate may influence downstream events. Most importantly, we have identified LSEC FcγRIIb-mediated endocytosis to be the Fc effector mechanism to eliminate cell-free HIV by Abs, which could inform development of HIV vaccine and Ab therapy.Keywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (AR066330)
This publication has 71 references indexed in Scilit:
- Rapid and Efficient Clearance of Blood-borne Virus by Liver Sinusoidal EndotheliumPLoS Pathogens, 2011
- The Genetic Bottleneck in Vertical Transmission of Subtype C HIV-1 Is Not Driven by Selection of Especially Neutralization-Resistant Virus from the Maternal Viral PopulationJournal of Virology, 2011
- Asymmetric total synthesis of (+)- and (−)-clusianone and (+)- and (−)-clusianone methyl enol ether via ACC alkylation and evaluation of their anti-HIV activityBioorganic & Medicinal Chemistry Letters, 2011
- FcγRIIB in autoimmunity and infection: evolutionary and therapeutic implicationsNature Reviews Immunology, 2010
- The growth and potential of human antiviral monoclonal antibody therapeuticsNature Biotechnology, 2007
- Monoclonal antibodies capable of discriminating the human inhibitory Fcγ‐receptor IIB (CD32B) from the activating Fcγ‐receptor IIA (CD32A): biochemical, biological and functional characterizationImmunology, 2007
- Inhibition of Lysosome and Proteasome Function Enhances Human Immunodeficiency Virus Type 1 InfectionJournal of Virology, 2005
- Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virionsProceedings of the National Academy of Sciences of the United States of America, 2003
- The Liver Is a Major Organ for Clearing Simian Immunodeficiency Virus in Rhesus MonkeysJournal of Virology, 2002
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996